Skip to main content
SpringerLink
Log in

Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients

  • Conference paper
Intensive Care Medicine

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 2007))

  • 993 Accesses

Abstract

Pneumocystis pneumonia remains one of the leading causes of morbidity and mortality among patients with acquired immunodeficiency syndrome (AIDS) all over the world [1]. However, pneumocystis pneumonia is also a life-threatening opportunistic infection that can occur in other immunocompromised patients, mainly in solid organ transplant recipients, in patients with cancer, and those treated for autoimmune or inflammatory diseases [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487–2498

    Article  CAS  PubMed  Google Scholar 

  2. Morris A, Beard CB, Huang L (2002) Update on the epidemiology and transmission of Pneumocystis carinii. Microbes Infect 4:95–103

    Article  PubMed  Google Scholar 

  3. Jacobs JL, Libby DM, Winters RA, et al (1991) A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med 324:246–250

    Article  CAS  PubMed  Google Scholar 

  4. Gajdusek DC (1957) Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19:543–565

    CAS  PubMed  Google Scholar 

  5. Limper AH, Offord KP, Smith TF, Martin WJ 2nd (1989) Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140:1204–1209

    CAS  PubMed  Google Scholar 

  6. Sepkowitz KA (1992) Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin Respir Infect 7:114–121

    CAS  PubMed  Google Scholar 

  7. Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267:832–837

    Article  CAS  PubMed  Google Scholar 

  8. Sepkowitz KA (1993) Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 17:S416–422

    PubMed  Google Scholar 

  9. Hughes WT, Price RA, Kim HK, Coburn TP, Grigsby D, Feldman S (1973) Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 82:404–415

    Article  CAS  PubMed  Google Scholar 

  10. Pagano L, Fianchi L, Mele L, et al (2002) Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years’ experience of infection in GIMEMA centres. Br J Haematol 117:379–386

    Article  PubMed  Google Scholar 

  11. De Castro N, Neuville S, Sarfati C, et al (2005) Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant 36:879–883

    Article  PubMed  Google Scholar 

  12. Godeau B, Coutant-Perronne V, Le Thi Huong D, et al (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246–251

    CAS  PubMed  Google Scholar 

  13. Gordon SM, LaRosa SP, Kalmadi S, et al (1999) Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 28:240–246

    Article  CAS  PubMed  Google Scholar 

  14. Radisic M, Lattes R, Chapman JF, et al (2003) Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 5:84–93

    Article  CAS  PubMed  Google Scholar 

  15. Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM (1993) Idiopathic CD4+ T-lymphocytopenia—four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 328:393–398

    Article  CAS  PubMed  Google Scholar 

  16. Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5–13

    Article  CAS  PubMed  Google Scholar 

  17. Hughes WT, Feldman S, Aur RJ, Verzosa MS, Hustu HO, Simone JV (1975) Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36:2004–2009

    Article  CAS  PubMed  Google Scholar 

  18. Lufft V, Kliem V, Behrend M, Pichlmayr R, Koch KM, Brunkhorst R (1996) Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 62:421–423

    CAS  Google Scholar 

  19. Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H (2000) Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118:712–720

    Article  CAS  PubMed  Google Scholar 

  20. Arend SM, Kroon FP, van’t Wout JW (1995) Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 155:2436–2441

    Article  CAS  PubMed  Google Scholar 

  21. Nuesch R, Bellini C, Zimmerli W (1999) Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis 29:1519–1523

    Article  CAS  PubMed  Google Scholar 

  22. Kovacs JA, Hiemenz J, Macher AM, et al (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663–671

    CAS  PubMed  Google Scholar 

  23. Kuhlman JE, Kavuru M, Fishman EK, Siegelman SS (1990) Pneumocystis carinii pneumonia: spectrum of parenchymal CT findings. Radiology 175:711–714

    CAS  PubMed  Google Scholar 

  24. Kovacs JA, Ng VL, Masur H, et al (1988) Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 318:589–593

    Article  CAS  PubMed  Google Scholar 

  25. LaRocque RC, Katz JT, Perruzzi P, Baden LR (2003) The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin Infect Dis 37:1380–133

    Article  PubMed  Google Scholar 

  26. Sing A, Trebesius K, Roggenkamp A, et al (2000) Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 38:1461–1467

    CAS  PubMed  Google Scholar 

  27. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822

    Article  PubMed  Google Scholar 

  28. Bondoc AY, White DA (2002) Granulomatous Pneumocystis carinii pneumonia in patients with malignancy. Thorax 57:435–437

    Article  CAS  PubMed  Google Scholar 

  29. Wakefield AE, Pixley FJ, Banerji S, et al (1990) Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 43:69–76

    Article  CAS  PubMed  Google Scholar 

  30. Ribes JA, Limper AH, Espy MJ, Smith TF (1997) PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 35:830–835

    CAS  PubMed  Google Scholar 

  31. Sing A, Roggenkamp A, Autenrieth IB, Heesemann J (1999) Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol 37:3409–3410

    CAS  PubMed  Google Scholar 

  32. Vidal S, de la Horra C, Martin J, et al (2006) Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 12:231–235

    Article  CAS  PubMed  Google Scholar 

  33. Maskell NA, Waine DJ, Lindley A, et al (2003) Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 58:594–597

    Article  CAS  PubMed  Google Scholar 

  34. Nevez G, Raccurt C, Vincent P, Jounieaux V, Dei-Cas E (1999) Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis 29:1331–1332

    Article  CAS  PubMed  Google Scholar 

  35. Leigh TR, Wakefield AE, Peters SE, Hopkin JM, Collins JV (1992) Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation 54:468–470

    Article  CAS  PubMed  Google Scholar 

  36. Larsen HH, Masur H, Kovacs JA, et al (2002) Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 40:490–494

    Article  CAS  PubMed  Google Scholar 

  37. Helweg-Larsen J, Jensen JS, Lundgren B (1997) Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes. Lancet 350:1363

    Article  CAS  PubMed  Google Scholar 

  38. Skelly M, Hoffman J, Fabbri M, Holzman RS, Clarkson AB Jr, Merali S (2003) S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet 361:1267–1268

    Article  CAS  PubMed  Google Scholar 

  39. Roblot F, Godet C, Le Moal G, et al (2002) Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 21:523–531

    Article  CAS  PubMed  Google Scholar 

  40. Zahar JR, Robin M, Azoulay E, Fieux F, Nitenberg G, Schlemmer B (2002) Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis 35:929–934

    Article  CAS  PubMed  Google Scholar 

  41. Bozzette SA, Sattler FR, Chiu J, et al (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 323:1451–1457

    Article  CAS  PubMed  Google Scholar 

  42. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L (1990) Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med 323:1444–1450

    Article  CAS  PubMed  Google Scholar 

  43. Kovacs JA, Hiemenz JW, Macher AM, et al (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663–671

    CAS  PubMed  Google Scholar 

  44. Safrin S, Lee BL, Sande MA (1994) Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J Infect Dis 170:912–917

    CAS  PubMed  Google Scholar 

  45. Bozzette SA, Sattler FR, Chiu J, et al (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 323:1451–1457

    Article  CAS  PubMed  Google Scholar 

  46. Delclaux C, Zahar JR, Amraoui G, et al (1999) Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients. Clin Infect Dis 29:670–672

    Article  CAS  PubMed  Google Scholar 

  47. Pareja JG, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215–1224

    Article  CAS  PubMed  Google Scholar 

  48. Hughes WT, Kuhn S, Chaudhary S, et al (1977) Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297:1419–1426

    Article  CAS  PubMed  Google Scholar 

  49. Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH (2000) Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 6:35–43

    Article  CAS  PubMed  Google Scholar 

  50. Rodriguez M, Fishman JA (2004) Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 17:770–782

    Article  PubMed  Google Scholar 

  51. Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T (1999) A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24:897–902

    Article  CAS  PubMed  Google Scholar 

  52. Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit, Hôpital St Louis, 1, avenue Claude Vellefaux, 75010, Paris, France

    G. Bollée, S. de Miranda & E. Azoulay

Authors
  1. G. Bollée
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. de Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science + Business Media Inc.

About this paper

Cite this paper

Bollée, G., de Miranda, S., Azoulay, E. (2007). Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients. In: Intensive Care Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2007. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49433-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-49433-1_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-49432-4

  • Online ISBN: 978-3-540-49433-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation